Catheter closure of atrial septal and ventricular septal defects using the Amplatzer devices

Heart Lung and Circulation

Volumn 12, Issue SUPPL. 2, 2003, Pages

  Hijazi, Ziyad M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CEFAZOLIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CINEANGIOCARDIOGRAPHY; CLINICAL STUDY; DEVICE; ECHOCARDIOGRAPHY; FOOD AND DRUG ADMINISTRATION; HEART ARRHYTHMIA; HEART ATRIUM SEPTUM DEFECT; HEART CATHETER; HEART CATHETERIZATION; HEART VENTRICLE SEPTUM DEFECT; HUMAN; IMPLANTATION; LONG TERM CARE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 0347531410     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1443-9506.2003.t01-3-.x     Document Type: Article

References (21)

1. Masura J, Gavora P, Formanek A et al. Transcatheter closure of secundum atrial septal defects using the new self-centering Amplatzer septal occluder: initial human experience. Cathet. Cardiovasc. Diagn. 1997; 42: 388-93.
2. Hijazi ZM, Cao QL, Patel HT et al. Transesophageal echocardiographic results of catheter closure of atrial septal defect in children and adults using the Amplatzer device. Am. J. Cardiol. 2000; 85: 1387-90.
3. Walsh KP, Wilmshurst PT, Morrison WL. Transcatheter closure of patent foramen ovale using the Amplatzer septal occluder to prevent recurrence of neurological decompression illness in divers. Heart 1999; 81: 257-61.
4. Tofeig M, Walsh KP, Chan C et al. Occlusion of Fontan fenestrations using the Amplatzer septal occluder. Heart 1998; 79: 368-70.
5. Podnar T, Martanovic P, Gavora P et al. Morphological variation of secundum-type atrial septal defects: feasibility for percutaneous closure using Amplatzer septal occluders. Cathet. Cardiovasc. Intervent. 2001; 53: 386-91.
6. Du ZD, Koenig P, Cao QL et al. Comparison of transcatheter closure of secundum atrial septal defect using the Amplatzer septal occluder associated with deficient versus sufficient rims. Am. J. Cardiol. 2002; 90: 865-9.
7. Hijazi ZM, Wang Z, Cao QL et al. Transcatheter closure of atrial septal defects and patent foramen ovale under intracardiac echocardiographic guidance: feasibility and comparison with transesophageal echocardiography. Cath. Cardiovasc. Intervent. 2001; 52: 194-9.
8. Walsh KP, Maadi IM. The Amplatzer septal occluder. Cardiol. Young 2000; 10: 493-501.
9. Gu X, Han YM, Berry J et al. A new technique for sizing of atrial septal defects. Cathet. Cardiovasc. Intervent. 1999; 46: 51-7.
10. Du ZD, Cao QL, Rhodes J, Heitschmidt M, Hijazi ZM. Choice of device size and results of transcatheter closure of atrial septal defect using the Amplatzer septal occluder. J. Intervent. Cardiol. 2002; 15: 287-92.
11. Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter non-randomized trial. J. Am. Coll. Cardiol. 2002; 39: 1836-44.
12. Berger F, Vogel M, Alexi-Mekishvili V et al. Comparison of results and complications of surgical and Amplatzer device closure of atrial septal defects. J. Thorac. Cardiovasc. Surg. 1999; 118: 674-8.
13. Cao Q, Radtke W, Berger F et al. Transcathter closure of multiple atrial septal defects. Initial results and value of two- and three-dimensional transesophageal echocardiography. Eur. Heart J. 2000; 21: 941-7.
14. Cao QL, Du ZD, Joseph A et al. Immediate and six-month results of the profile of the Amplatzer septal occluder as assessed by transesophageal echocardiography. Am. J Cardiol 2001; 88: 754-9.
15. Hill SL, Berul CI, Patel HT et al. Early ECG abnormalities associated with transcatheter closure of atrial septal defects using the Amplatzer® septal occluder. J. Interv. Card. Electrophysiol. 2000; 4: 469-74.
16. Amin Z, Go X, Berry JM et al. New device for closure of muscular ventricular septal defects in a canine model. Circulation 1999; 100: 320-8.
17. Thanopoulos BD, Tsaousis GS, Konstadopoulou GN, Zarayelyan AG, Transcatheter closure of muscular ventricular septal defects with the Amplatzer ventricular septal defect occluder: initial application in children. J. Am. Coll. Cardiol. 1999; 33: 1395-9.
18. Waight DJ, Bacha EA, Kahana M, Cao QL, Heitschmidt M, Hijazi ZM: Catheter therapy of swiss cheese ventricular septal defects using the Amplatzer Muscular VSD Occluder. Cath. Cardiovasc. Intervent. 2002; 55: 355-61.
19. Hijazi ZM, Hakim F, Al-Fadley F, Abdelhamid J, Cao QL. Transcatheter closure of single muscular ventricular septal defects using the Amplatzer Muscular VSD Occluder: Initial results and technical considerations. Cathet. Cardiovasc. Interv. 2000; 49: 167-72.
20. Backer CL, Winters RC, Zales VR et al. The restrictive ventricular septal defect: how small is too small to close? Ann. Thorac. Surg. 1993; 56: 1014.
21. Hijazi ZM, Hakim F, Haweleh AA et al. Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder. Cathet. Cardiovasc. Intervent. 2002; 56: 508-15.